Candesartan for hypertension

Medical Letter on Drugs and Therapeutics

Volumn 40, Issue 1040, 1998, Pages 109-110

  Abramowicz, Mark ^g   Rizack, Martin A ^a   Goodstein, Donna ^g   Faucard, Amy ^g   Peter, Doris ^g   Hansten, Philip D ^b   Steigbigel, Neal H ^c   Kim, Richard Brian ^d   Long, Scott ^e   Mukherjee, Sandip K ^f   Aschenbrenner, Marianne ^g  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN; CANDESARTAN HEXETIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; IRBESARTAN; LOSARTAN POTASSIUM; NIFEDIPINE; UNCLASSIFIED DRUG; VALSARTAN; WARFARIN;

ANGIONEUROTIC EDEMA; CLINICAL TRIAL; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; KIDNEY CELL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; RECEPTOR BLOCKING; SHORT SURVEY;

ADMINISTRATION, ORAL; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; CLINICAL TRIALS; DOUBLE-BLIND METHOD; HALF-LIFE; HUMANS; HYPERTENSION; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 3643084355     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. JV Gainer et al, N Engl J Med, 339:1285, Oct 29, 1998
2. M Reif et al, Am J Cardiol, 82:961, October 15, 1998
3. OK Andersson and S Neldam, Blood Pressure, 7:53, 1998
4. A Zanchetti et al, J Hum Hypertens, 11 suppl 2:S57, 1997
5. H Franke, J Hum Hypertens, 11 suppl 2:S61, 1997
6. C Farsang et al, Am J Hypertens, 10:80A, 1997